Skip to main content
logo
Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
17.33
-0.94 (-5.12%)
Oct 13, 2026, 3:05 PM EDT - Market open

Odyssey Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-160.03-148.65-129.32-125.94-124.67
Depreciation & Amortization
4.564.915.194.912.76
Loss (Gain) From Sale of Assets
1.591.3600.05-
Asset Writedown & Restructuring Costs
-5.44--0.24
Loss (Gain) From Sale of Investments
-1.01-1.52-4.46-3.26-
Stock-Based Compensation
15.8914.328.696.265.52
Other Operating Activities
14.76-0.615.734.3516.85
Change in Accounts Payable
0.762.06-1.72.243.27
Change in Other Net Operating Assets
-8.64-6.79-1.61-1.35-3.81
Operating Cash Flow
-132.13-129.47-117.47-112.73-99.84
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0.61-1.23-0.76-5.06-13.03
Sale of Property, Plant & Equipment
0.50.36-0.02-
Investment in Securities
-337.91-103.0797.55-159.99-
Investing Cash Flow
-338.02-103.9496.78-165.02-13.03

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
----4.88
Long-Term Debt Repaid
----4.76-
Net Debt Issued (Repaid)
----4.764.88
Issuance of Common Stock
295.663.190.510.260.08
Other Financing Activities
---1.04--
Financing Cash Flow
389.37215.6526.9892.08182.72

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
0.050.320.050.01-0.02
Net Cash Flow
-80.73-17.456.34-185.6769.83

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-132.74-130.7-118.24-117.78-112.87
Free Cash Flow Growth
-----
Free Cash Flow Margin
-134079.80%-4391.80%-2643.89%-11358.15%-
Free Cash Flow Per Share
-11.65-44.08-146.51-181.76-252.05
Levered Free Cash Flow
--85.05-66.42-78.21-
Unlevered Free Cash Flow
--85.04-66.41-78-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
0.020.010.020.160.29
Cash Income Tax Paid
0.220.260.50.32-
Change in Working Capital
-7.88-4.73-3.310.9-0.54
SEC Filings: 10-K · 10-Q